But Gary claims he has tried and failed to get the drug free alternative on the NHS despite it being available for prescription since April 2018.

Chronic pain syndrome is a difficult entity to manage for clinicians.[ 1] The management is multimodal that comprises pharmacological approach in the form of opioids, nonsteroidal anti-inflammatory drugs, gabapentinoids, antidepressants, antiepileptic agents, and a lot of other nonopioid medications. The patients are also advised nonpharmacological therapies such as physiotherapy sessions, acupressure, acupuncture, aromatherapy, and TENS.If you’re new to Actipatch and aren’t sure which version of this product is the best for you, there are 4 options you can choose from. Each one works in the same way, but maybe easier to use on different areas of the body: Read more at http://www.bielcorp.com/bioelectronics-wins-high-commendation-most-innovative-otc-product-award-otc-bulletin/ ActiPatch® Pain Relief Therapy Featured on Leading Healthcare Show in Spain ActiPatch is free from medication or hormones, and therefore should be fine to use at the same time as your medication. However, if you’re unsure you should always speak to your doctor or Chemist 4 U pharmacist before using this product, as they will help you to be sure this

Last month, the Royal College of General Practitioners announced that GPs did not want to prescribe them for long-term use. Prescribing policies on products for which there is no national direction are decided at local level, based on available clinical evidence and cost-effectiveness relative to other products. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7. PMID: 34062143.

Actipatch is a therapy device which can help you to manage pain in your muscles and joints. It’s completely medication-free, working wherever you place it on the body to ease pain and inflammation without creating any uncomfortable heat or vibrations. If you suffer from chronic pain and are looking for long-term relief, ActiPatch could be the perfect solution for you. Primary care prescribers must be familiar with the drug to take on prescribing responsibility or must get the required information. If you use a pacemaker, we do not recommend that you use your ActiPatch directly over the pacemaker itself. Do not use this product when showering or bathing, this product should not be submerged in water. When the battery of this product has run out, you should not attempt to replace it. Your device will not be able to provide optimal treatment after 720 hours and should be thrown away with your regular household waste. Knee pain therapy device– This one comes with a reusable knee strap, which holds this product in place on your It may not work in every single scenario, but medical professionals need to sit up and take notice of a risk-free treatment which could provide a drug-free alternative for thousands of people suffering through the agony of chronic pain.”

BioElectronics’ Smart Insole rides the wave of wearable tech’ that looks likely to crash into the consumer healthcare market. It offers an innovative way to deal with an unglamorous and difficult-to-treat problem.” Unfortunately, the good it is doing is being ignored. The financial side of it especially is just amazing. The ActiPatch brand provides a striking and distinctive design to help differentiate this new and alternative product in a sector that is already dominated by other leading brands.” The complete details on the award winners are available in the 2013 OTC Awards Supplement http://www.otc-bulletin.com/awards/pdfs/WinnersSupplement2013.pdf. ActiPatch Canada Commercial

Pharmacy product

ActiPatch is drug-free and therefore should not have any side effects when used as recommended by the manufacturer. However, if you do experience any side effects while using this product, you should speak to your doctor or Chemist 4 U pharmacist right away. For more information about reporting the side effects of treatments, please see the MHRA’s Yellow Card Scheme.